2011 Check presentation to Dana Farber for $70,000

For 3 years Voices of Hope has supported the Dana-Farber and donated $130,000 to cancer research.  In 2012 we continue on our quest to cure cancer by supporting The Massachusetts General Hospital's Termeer Center for Targeted Therapies...see below.  We are very excited to be joining forces with another fantastic and dedicated team. 

Research

As long as there is research, there is hope! 

Voices of Hope is proud to support:

The Henri and Belinda Termeer Center for Targeted Therapies offers new hope to patients and their families at the Massachusetts General Hospital Cancer Center and beyond, as the center defines the future of cancer therapy.

Led by José Baselga, MD, PhD, chief of Hematology/Oncology, associate director of the Cancer Center and world-renowned pioneer in personalized cancer medicine, the Termeer Center offers a comprehensive translational research program to speed the discovery and delivery of new targeted therapies to patients with early and advanced stage cancers.

The Termeer Center brings together cutting-edge research resources and provides a foundation for collaborations among physicians and investigators from a broad spectrum of biomedical disciplines, resulting in a rapidly expanding arsenal of weapons against cancer. Leading specialists from the Cancer Center’s 23 disease centers participate in the Termeer Center by enrolling their patients in its fast-growing portfolio of Phase I, Phase II and Phase III clinical trials.

The cycle of discovery is swift and efficient, with newly identified genetic abnormalities revealing new information about cancer pathways and creating novel investigative possibilities, not only for Mass General researchers but for scientific collaborators around the world. The Termeer Center’s goal is to cut the average time for drug development from ten years to five and, with more clinical trials, improve access to therapy for patients. With hundreds of new anti-cancer therapies now in the development pipeline and countless patients waiting for targeted drugs that match their individual tumors, the Termeer Center’s work is vital and timely.

To learn more Click here »